Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2Recruiting 2Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1Cardiotoxicity 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Angiotensin-Converting Enzyme Inhibitors × Clear all
NCT04245644 2024-03-12

CAOS

IRCCS San Raffaele

Unknown
800 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT04092309 2020-04-03

Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow Transplantation

University of Athens

Phase NA Unknown
90 enrolled

Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡